Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has provided an announcement.
Clarity Pharmaceuticals Ltd. has announced that Citigroup Global Markets Australia Pty Limited and its related entities have ceased to be substantial holders of the company’s shares as of September 5, 2025. The changes in relevant interests involve a decrease in shares held by Citibank, N.A. Sydney Branch and Citigroup Global Markets Australia Pty Limited, while Citigroup Global Markets Limited has increased its relevant interest in the shares. This shift in shareholding may impact the company’s market dynamics and stakeholder interests.
The most recent analyst rating on (AU:CU6) stock is a Buy with a A$5.70 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 3,341,892
Technical Sentiment Signal: Sell
Current Market Cap: A$1.18B
Learn more about CU6 stock on TipRanks’ Stock Analysis page.